Nanotechnology-Driven Antioxidants and Immunomodulators for Polycystic Ovary Syndrome Therapy

Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder that involves chronic inflammation and oxidative stress, which are not adequately addressed by traditional hormonal treatments. This document discusses the potential of nanotechnology-driven therapies, specifically nano-antioxidants and immuno-modulators, to target inflammation and immune dysregulation in PCOS. By focusing on the mechanistic link between inflammation and PCOS, the chapter highlights how engineered nano-antioxidants can remove excess reactive oxygen species and restore redox balance, while immuno-modulators can reduce systemic and local inflammation. The document emphasizes the promise of nanotechnology in developing innovative treatments for PCOS.